Entry |
|
Name |
Belumosudil (USAN) |
Formula |
C26H24N6O2
|
Exact mass |
452.1961
|
Mol weight |
452.51
|
Structure |
|
Remark |
Product (DG03109): | D11816<JP/US> |
|
Efficacy |
Autoimmune disease treatment, Rho-associated kinase inhibitor |
Comment |
Treatment of autoimmune diseases
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AA Selective immunosuppressants
L04AA48 Belumosudil
D11815 Belumosudil (USAN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
AGC group
ROCK2
D11815 Belumosudil (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8y C 8.8200 -17.8500
2 C8y C 8.8200 -19.2500
3 C8x C 10.0324 -19.9500
4 C8x C 11.2449 -19.2500
5 C8y C 11.2449 -17.8500
6 C8x C 10.0324 -17.1500
7 C8x C 7.4885 -17.4174
8 N5x N 6.6656 -18.5500
9 N4x N 7.4885 -19.6826
10 N1b N 12.4760 -17.1390
11 C8y C 12.4757 -15.7501
12 C8y C 13.6762 -15.0566
13 C8y C 13.6759 -13.6566
14 C8x C 12.4633 -12.9569
15 C8x C 11.2628 -13.6504
16 C8x C 11.2631 -15.0504
17 C8x C 14.8888 -15.7563
18 N5x N 16.1011 -15.0560
19 C8y C 16.1007 -13.6560
20 N5x N 14.8881 -12.9563
21 C8y C 17.3150 -12.9545
22 C8x C 18.5068 -13.6424
23 C8y C 19.7191 -12.9422
24 C8x C 19.7190 -11.5422
25 C8x C 18.5272 -10.8544
26 C8x C 17.3149 -11.5545
27 O2a O 20.9507 -13.6531
28 C1b C 22.1487 -12.9610
29 C5a C 23.3349 -13.6457
30 N1b N 24.5266 -12.9573
31 O5a O 23.3352 -15.0498
32 C1c C 25.7160 -13.6438
33 C1a C 26.9061 -12.9563
34 C1a C 25.7164 -15.0498
BOND 38
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 2
9 8 9 1
10 2 9 1
11 5 10 1
12 10 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 12 17 1
20 17 18 2
21 18 19 1
22 19 20 2
23 13 20 1
24 19 21 1
25 21 22 2
26 22 23 1
27 23 24 2
28 24 25 1
29 25 26 2
30 21 26 1
31 23 27 1
32 27 28 1
33 28 29 1
34 29 30 1
35 29 31 2
36 30 32 1
37 32 33 1
38 32 34 1
|